Harvard Bioscience Balance Sheet - Quarterly (NASDAQ:HBIO)

Add to My Stocks
$5.15 $0 (0%) HBIO stock closing price Jul 16, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Harvard Bioscience balance sheet. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Harvard Bioscience stock analysis, and provides insights into the firm's financial performance. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Harvard Bioscience had a long term debt of $61.56M at the end of 2018 Q1. To understand the debt servicing capacity of the company, one needs to look at Harvard Bioscience operating cash flow and Harvard Bioscience revenue also. Harvard Bioscience debt to equity ratio is 0.79.

View and download Harvard Bioscience quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Cash5.99M5.73M5.83M4.72M4.59M5.59M5.34M3.63M4.17M6.74M
Marketable Securities----------
Receivables21.91M20.44M20.18M20.74M20.24M19.92M19.57M20.97M22.35M21.42M
Inventory27.9M21.35M21.38M20.37M20.28M19.95M21.23M22.2M22.21M22.34M
Raw Materials15.46M10.02M10.76M10.3M9.69M9.79M10.83M11.03M10.69M10.49M
Work In Progress4.78M1.04M-----1.08M1.13M-
Finished Goods7.65M10.28M9.73M9.3M9.68M9.34M9.46M10.09M10.39M10.95M
Notes Receivable----------
Other Current Assets----------
Total Current Assets
55.81M47.53M47.39M45.83M45.12M45.47M46.15M46.81M48.74M50.54M
Property Plant & Equipment21.77M20.49M20.65M20.06M19.34M18.9M21.98M22.06M22.15M21.92M
Accumulated Depreciation15.95M16.35M16.39M15.77M15.07M14.6M16.71M16.42M16.41M16.01M
Net Property Plant & Equipment
5.82M4.14M4.26M4.28M4.26M4.29M5.26M5.64M5.73M5.9M
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges1.1M-1.27M1.23M1.17M1.15M--1.03M-
Intangibles106.86M57.17M57.62M57.37M56.68M56.71M59.71M60.57M62.23M62.45M
Deposits & Other Assets1.35M---------
Total Assets
170.94M109.35M110.67M108.85M107.39M107.76M112.17M114.08M117.88M120.21M
Notes Payable---------1.36M
Accounts Payable7.35M5.4M5.6M5.58M5.83M6.19M6.14M6.57M6.17M8.78M
Current Portion Long-Term Debt1.41M2.76M2.76M2.77M2.72M2.37M2.37M2.38M2.37M2.45M
Current Portion Capital Leases----------
Accrued Expenses8.22M4.93M4.69M3.86M4.42M4.77M4.71M4.19M5.85M4.31M
Income Taxes Payable---------2.24M
Other Current Liabilities5.28M--1.01M1.07M1.26M1.2M1.68M1.49M1.62M
Total Current Liabilities
22.28M14.04M13.94M13.23M14.05M14.6M14.44M14.85M15.89M19.4M
Mortgages----------
Deferred Taxes/Income1.7M3.96M6.62M6.55M6.46M6.41M6.53M6.07M6.11M3.77M
Convertible Debt----------
Long-Term Debt61.56M8.98M9.67M10.41M10.93M11.37M12.66M13.77M14.77M16.45M
Non-Current Capital Leases----------
Other Long-Term Liabilities6.09M1.46M3.52M3.43M3.23M3.17M2.64M2.72M2.9M2.98M
Total Liabilities
91.65M28.45M33.77M33.64M34.68M35.56M36.28M37.42M39.68M42.61M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus220.02M218.79M217.63M216.72M215.84M215.13M214.13M213.1M212.09M211.45M
Retained Earnings-121.03M-116.96M-117.96M-117.54M-117.16M-116.03M-114.71M-113.07M-112.35M-111.72M
Treasury Stock10.66M10.66M10.66M10.66M10.66M10.66M10.66M10.66M10.66M10.66M
Other Liabilities-9.44M-10.67M-12.51M-13.71M-15.7M-16.65M-13.28M-13.11M-11.29M-11.88M
Shareholders Equity79.29M80.9M76.9M75.21M72.71M72.19M75.89M76.66M78.19M77.59M
Total Liabilities & Shareholders Equity170.94M109.35M110.67M108.85M107.39M107.76M112.17M114.08M117.88M120.21M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Most investors just check the Harvard Bioscience stock price, and Harvard Bioscience historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Harvard Bioscience PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: HBIO total assets, which was at $170.94M for 2018 Q1 is a balance sheet item representing value of what Harvard Bioscience owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Harvard Bioscience is $91.65M. Shareholders equity comes under liabilities as it is money the company owes the holders of HBIO stock.

Harvard Bioscience Balance Sheet - Key Ratios

Current ratio
2.51
Debt to equity ratio
0.79
Asset turnover ratio
0.76
Receivables turnover
5.05
Price to book ratio
2.37